SCHEMBL30863530

SCHEMBL30863530

COc1ccc(N)c2ccncc12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.58
EP300 Q09472 2/20 0.56
KAT8 Q9H7Z6 2/20 0.56
AXL P30530 1/20 0.50
KAT2B Q92831 1/20 0.50
MAOA P21397 2/20 0.45
CYP3A4 P08684 2/20 0.43
CYP1A2 P05177 2/20 0.43
CYP2C9 P11712 2/20 0.43
CYP2C19 P33261 2/20 0.43
LMNA P02545 1/20 0.43
CYP2D6 P10635 1/20 0.43
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA9 Q16790 1/20 0.42
CHUK O15111 1/20 0.42
PRKD3 O94806 1/20 0.42
PRKCG P05129 1/20 0.42
PRKCB P05771 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5661372 1.00 IDO1 (0.58) IDO1EP300KAT8AXLKAT2B
SCHEMBL12426316 0.86 MAOA (0.52) IDO1EP300KAT8MAOACYP1A2
SCHEMBL5894746 0.80 AXL (0.72) EP300KAT8AXLKAT2BCYP3A4
SCHEMBL11086461 0.79 MAOA (0.46) IDO1EP300KAT8AXLKAT2B
SCHEMBL2382250 0.78 NTRK1 (0.57) MAOACYP3A4CYP1A2CYP2C9CYP2C19
SCHEMBL2381282 0.78 AXL (0.55) AXLMAOACYP3A4CYP1A2CYP2C19
SCHEMBL31483347 0.78 AXL (0.55) AXLMAOACYP3A4CYP1A2CYP2C19
SCHEMBL19660423 0.76 MAOA (0.46) IDO1EP300KAT8MAOACYP1A2
SCHEMBL14604837 0.75 MAOA (0.42) MAOACYP3A4CYP1A2CYP2C9CYP2C19
SCHEMBL14571327 0.75 MAOA (0.42) MAOACYP3A4CYP1A2CYP2C19LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4581017-A1 NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS Biodol Therapeutics (FR) 2025-07-09 EP disclosed
WO-2024079072-A1 NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS BIODOL THERAPEUTICS (FR) 2024-04-18 WO disclosed